Ibrutinib resistance-mechanisms and options

In this presentation from Lymphoma & Myeloma 2016, Dr. Y. Lynn Wang discusses ibrutinib resistance-mechanisms in the treatment of chronic lymphocytic leukemia (CLL).

Click to Earn CME Credit: http://bit.ly/2lDPthL

© 2016 Imedex, LLC.